We are a group of dedicated people who refuse to believe that the best treatments for autoimmune diseases have already been found and developed.
We are singularly focused, resource stingy, pursuing a specific target, while building a pathway to profitability.
Founder - Interim CEO
Jack is a dedicated researcher of neuroimmunology, who has committed himself to the eradication of suffering from neurodegeneration. Jack has familial relationships with both multiple sclerosis and Alzheimer's Disease.
Chief Scientific Officer
Jerry is a senior scientist, with extensive experience in assay development and signal transduction pathway investigation in neurodegeneration, inflammation and autoimmune diseases, especially amyotrophic lateral sclerosis (ALS). Past positions includes the ALS TDI, Wyeth and Sanofi Genzyme.
Chief Regulatory Officer
Richard is a passionate physician-scientist with extensive academic and pharmaceutical industry experience in neurodegenerative disorders, especially Alzheimer’s disease. Drug development expertise from late preclinical through late stage. Medical training in psychiatry and nuclear medicine. Past positions include senior leadership with Pfizer; CereSpir; JANSSEN; and Merck Research Laboratories